Senseonics Holdings and Ascensia Diabetes Care announced that Eversense has been granted an integrated CGM (iCGM) designation ...

Avricore has partnered with Ascensia Diabetes Care to integrate their blood glucose monitoring systems, CONTOUR®NEXT GEN and ...

Continuous glucose monitoring industry is projected to witness a CAGR of 12.6% during the period 2024-2032. This growth can ...

Dianne Mattiace shows that managing diabetes shouldn’t get in the way of enjoying your retirement, thanks in part to a game ...

Global Network Point of Care Glucose Testing Industry is reach a valuation of nearly US$ 2.5 Bn by 2032 and at a growth rate ...

As is par for the course these days, my inbox this month has been filled with diabetes tech announcements: Edgepark is adding a new insulin delivery system to its portfolio, Insulet’s Omnipod is fueli ...

As the first fully implantable device in the category, Eversense has been authorized to be marketed as an iCGM through the FDA's De Novo pathway, by establishing the special controls that will serve ...

Avricore has partnered with Ascensia Diabetes Care to integrate their blood glucose monitoring systems, CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore's HealthTab platform. The collaboration ...